Immunisation Coalition: 2025 Pertussis webinar
这 Immunisation Coalition will host its 2025 Pertussis Webinar on 17 September 2025. Moderated by Dr Andrew Minton, the webinar will feature Dr Andrew Baird.
日期： 17 September 2025
时间： 6:00–7:00 pm AEDT
Learn more and register on the Immunisation Coalition event page.
UQ news: Billion-dollar deal takes UQ vaccine tech to the world
Pharmaceutical company Sanofi has acquired the rights to a unique vaccine technology developed by University of Queensland (UQ) scientists.
The Molecular Clamp platform “streamlines vaccine development across different viral families” according to UQ researchers.
Read more on the UQ website.
Benchmarque Group: 2025 Immunisation seminar series
Registrations are now open for Benchmarque Group’s 1-day immunisation seminars, to be held between September and November 2025 in multiple Australian cities.
- Sydney: 4日 September
- Melbourne: 17日 September
- Gold Coast: 2nd October
- Sunshine Coast: 22nd October
- Brisbane: 29日 October
- Hobart 13日 November
- Adelaide: 26日 November
Learn more and register now on the Benchmarque Group event page.
The Lancet: Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study
A recent UK study finds maternal RSV vaccination has reduced the risk of hospitalisation for infants with RSV whose mother received a vaccine during pregnancy, within the recommended time frame.
Maternal vaccinations were introduced in the UK in August to September 2024, for pregnant people from 28 weeks’ gestation.
Read the full Williams TC, Marlow R, Cunningham S et al. article 在 The Lancet’s Child and Adolescent Health website.
MVEC on LinkedIn
We are now on LinkedIn! Please follow our page support us by sharing the news with your network.
AAP FactCheck debunks vaccine misinformation about COVID-19 vaccines
AAP FactCheck has debunked 2 vaccines myths that have been circulating: no, a study did not report that a rise in cancer rates was explained by COVID-19 vaccine mandates; and no, researchers did not find COVID-19 mRNA vaccines killed more people than the virus.
According the to the FactCheck team, posts circulating on social media that imply rising cancer rates are explained by COVID-19 vaccination have no basis. Social media comments linking cancer rates with COVID-19 vaccination have been published in connection with a study on rising bowel cancer rates based on 1990 to 2020 data, well before COVID-19 vaccines were introduced.
Read AAP FactCheck: Study's cancer rate rise not linked to COVID vaccines for a breakdown of why the claim is false.
AAP FactCheck has also debunked online claims that German scientists announced new evidence proving COVID-19 mRNA vaccines killed more people than the virus. The researchers made no such finding.
Read AAP FactCheck: No, German study did not blame mRNA vaccines for excess pandemic deaths for more details.
Go to MVEC：COVID-19 for information about COVID-19 disease, epidemiology and vaccination.
ProPublica: RFK Jr. Wants to Change a Program That Stopped Vaccine Makers From Leaving the U.S. Market. They Could Flee Again.
Earlier this week Robert F Kennedy Jr announced plans to overhaul the US program that compensates people injured by vaccination.
The Vaccine Injury Compensation Program (VICP) was developed in the 1980s as a means for people who experience rare but serious side effects from vaccines to receive compensation from pharmaceutical companies, without manufacturers being found negligent. The program was developed at a time when lawsuits drove vaccine makers from the market.
The VICP covers vaccines routinely recommended to children or pregnant people. Changes to the program could potentially prompt vaccines makers to withdraw from the US market like they did in the 1980s.
Read the ProPublica article in full
CNN: Kennedy announces plan to reform Vaccine Injury Compensation Program
The Kids: RSV immunisation guidance tool
The Kids Research Institute has developed a tool designed to help current and future parents and caregivers, as well as healthcare providers, determine the best options for RSV immunisation depending on individual circumstances.
The tool has been developed based in Western Australia, but it aligns with RSV programs in other jurisdictions too. Check your local state or territory immunisation authority for accurate information.
The Kids: RSV immunisation guidance tool
Save the date: MVEC Immunisation Skills Workshop in October
MVEC’s next Immunisation Skills Workshop will be held in Melbourne on Friday 24 October 2025. This half-day, interactive event is designed to educate and upskill accredited immunisation providers.
Registrations opening soon. Read more about this event and whether it’s right for you on our event page.
MVEC: Immunisation Skills Workshop – Friday 24 October 2025
Updated immunisation reference page: Travel and immunisation
International travel carries an increased likelihood of exposure to infections, illness or injury that a person may otherwise not be exposed to. When travelling overseas it is important to obtain vaccine recommendations from a healthcare professional trained in travel medicine to ensure optimal protection when in another country.
MVEC has recently updated its travel immunisation reference page. The updated page includes recommendations for routine vaccines, travel-specific vaccines and non-vaccine precautions. The reference also covers how and when to access preventative care before travel, and considerations for high-risk groups.